Pulmonary Mycobacteriosis in a Patient Receiving Chronic Methotrexate Treatment

Arch Bronconeumol (Engl Ed). 2018 Apr;54(4):225-226. doi: 10.1016/j.arbres.2017.09.009. Epub 2017 Nov 3.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antitubercular Agents / therapeutic use
  • Bronchoalveolar Lavage Fluid / microbiology
  • Community-Acquired Infections / etiology*
  • Community-Acquired Infections / microbiology
  • Diagnosis, Differential
  • Drug Substitution
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Methotrexate / therapeutic use*
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / etiology*
  • Mycobacterium Infections, Nontuberculous / microbiology
  • Mycobacterium avium Complex / isolation & purification
  • Mycobacterium avium-intracellulare Infection / drug therapy
  • Mycobacterium avium-intracellulare Infection / etiology
  • Mycobacterium avium-intracellulare Infection / microbiology
  • Nontuberculous Mycobacteria / isolation & purification*
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology*
  • Opportunistic Infections / microbiology
  • Pityriasis Lichenoides / drug therapy
  • Sarcoidosis / diagnosis

Substances

  • Adrenal Cortex Hormones
  • Antitubercular Agents
  • Immunosuppressive Agents
  • Methotrexate